321 related articles for article (PubMed ID: 7779451)
1. To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?
Workman P
Hum Exp Toxicol; 1995 Feb; 14(2):222-5. PubMed ID: 7779451
[No Abstract] [Full Text] [Related]
2. [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].
Hainaut P
Bull Cancer; 2000 Jan; 87(1):11-8. PubMed ID: 10673626
[No Abstract] [Full Text] [Related]
3. Recent advances in p53 research and cancer treatment.
Suzuki K; Matsubara H
J Biomed Biotechnol; 2011; 2011():978312. PubMed ID: 21765642
[TBL] [Abstract][Full Text] [Related]
4. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
Wang XW; Harris CC
Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
[TBL] [Abstract][Full Text] [Related]
5. [Rescue of nonsense mutated p53 by readthrough leads to apoptosis in cancers cells].
Floquet C; Rousset JP; Bidou L
Med Sci (Paris); 2011; 27(6-7):585-6. PubMed ID: 21718640
[No Abstract] [Full Text] [Related]
6. The p53 tumour suppressor protein.
Hickman ES; Helin K
Biotechnol Genet Eng Rev; 2000; 17():179-211. PubMed ID: 11255666
[No Abstract] [Full Text] [Related]
7. p53 and human cancers.
Lane DP
Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
[TBL] [Abstract][Full Text] [Related]
8. [DNA damage-induced signal pathway of p53 as a tumor suppressor and the gene mutation in human cancer].
Tsuchida N; Gao C; Tsuchida Y; Nakajima T; Nishigaki R
Tanpakushitsu Kakusan Koso; 2000 Jul; 45(10):1742-51. PubMed ID: 10897687
[No Abstract] [Full Text] [Related]
9. Revealing the intricacies of cancer.
Verhagen AM; Lock P
Genome Biol; 2002; 3(6):REPORTS4015. PubMed ID: 12093370
[TBL] [Abstract][Full Text] [Related]
10. Living with p53, dying of p53.
Aylon Y; Oren M
Cell; 2007 Aug; 130(4):597-600. PubMed ID: 17719538
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt MS; Bennett WP; Hollstein M; Harris CC
Cancer Res; 1994 Sep; 54(18):4855-78. PubMed ID: 8069852
[No Abstract] [Full Text] [Related]
12. 11th Ernst Klenk Lecture. The p53 tumor suppressor gene and product.
Levine AJ
Biol Chem Hoppe Seyler; 1993 Apr; 374(4):227-35. PubMed ID: 8329141
[No Abstract] [Full Text] [Related]
13. DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis.
Canman CE; Chen CY; Lee MH; Kastan MB
Cold Spring Harb Symp Quant Biol; 1994; 59():277-86. PubMed ID: 7587079
[No Abstract] [Full Text] [Related]
14. Functions of p53 suppress critical consequences of damage and repair in the initiation of cancer.
Tlsty TD
Cancer Cell; 2002 Jul; 2(1):2-4. PubMed ID: 12150817
[TBL] [Abstract][Full Text] [Related]
15. p53: DNA damage, DNA repair, and apoptosis.
Götz C; Montenarh M
Rev Physiol Biochem Pharmacol; 1996; 127():65-95. PubMed ID: 8533012
[No Abstract] [Full Text] [Related]
16. Apoptosis, cancer and the p53 tumour suppressor gene.
Lee JM; Bernstein A
Cancer Metastasis Rev; 1995 Jun; 14(2):149-61. PubMed ID: 7554031
[TBL] [Abstract][Full Text] [Related]
17. The dual role of mutant p53 protein in chemosensitivity of human cancers.
Mueller H; Eppenberger U
Anticancer Res; 1996; 16(6B):3845-8. PubMed ID: 9042268
[TBL] [Abstract][Full Text] [Related]
18. The p53 tumour suppressor gene and product.
Levine AJ
Cancer Surv; 1992; 12():59-79. PubMed ID: 1638548
[No Abstract] [Full Text] [Related]
19. The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
Sheikh MS; Huang Y; Fernandez-Salas EA; El-Deiry WS; Friess H; Amundson S; Yin J; Meltzer SJ; Holbrook NJ; Fornace AJ
Oncogene; 1999 Jul; 18(28):4153-9. PubMed ID: 10435597
[TBL] [Abstract][Full Text] [Related]
20. P53, cell cycle control and apoptosis: implications for cancer.
Kastan MB; Canman CE; Leonard CJ
Cancer Metastasis Rev; 1995 Mar; 14(1):3-15. PubMed ID: 7606818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
